EMEA-003600-PIP01-24 - paediatric investigation plan
Indapamide
Ramipril
PIPHuman
Key facts
- Active Substance
- Indapamide
- Ramipril
- Therapeutic area
- Vascular disorders
- Decision number
- P/0267/2024
- PIP number
- EMEA-003600-PIP01-24
- Pharmaceutical form(s)
- Modified-release tablet
- Condition(s) / indication(s)
- Treatment of hypertension
- Route(s) of administration
- Oral use
- Contact for public enquiries
Adamed Pharma S.A.
E-mail: RA-EU@adamed.com
Tel: +48 697063916- Decision type
- W: decision granting a waiver in all age groups for all conditions or indications
- Decision date